You are here
BIOHELIX CORPORATION
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Low-cost, rapid quantitative Isothermal Assay for HIV RNA using ZNA
Amount: $600,000.00DESCRIPTION (provided by applicant): In this Phase I project, we propose to investigate a novel primer chemistry and probe detection system called the Zip nucleic acids (ZNA ). ZNAs are oligonucleoti ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health -
Integrated molecular diagnostic system for the point-of-care
Amount: $482,810.00DESCRIPTION (provided by applicant): This STTR-AT-NIAID seeks to develop an integrated nucleic acid system based on research done by Catherine Klapperich's laboratory at Boston University. The BU ...
STTRPhase I2011Department of Health and Human Services National Institutes of Health -
Molecular tests for malaria that can be performed with unprocessed samples
Amount: $546,867.00DESCRIPTION (provided by applicant): This SBIR-AT-NIAID Phase I application addresses the problem of malaria diagnostics in resource- limited settings. BioHelix, has developed an isothermal nucleic ac ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health -
Low cost molecular assay for HIV
Amount: $2,835,000.00DESCRIPTION (provided by applicant): We propose to develop a rapid, low cost, threshold assay for the detection of HIV infection of HIV vaccination trial participants. The assay we propose to develop ...
SBIRPhase II2009Department of Health and Human Services National Institutes of Health -
Genotyping assays for the most common mutations associated with abacavir hypersen
Amount: $143,606.00DESCRIPTION (provided by applicant): We propose to develop a near patient assays to score 2 SNPs associated with abacavir-severe cutaneous adverse reactions (SCAR); i.e., HLA B*5701 and the Hsp70-Hom ...
SBIRPhase I2009Department of Health and Human Services National Institutes of Health -
Lateral flow assay for detecting colonization by Streptococcus agalactiae
Amount: $201,042.00DESCRIPTION (provided by applicant): Streptococcus agalactiae, a.k.a. group B streptococcus (GBS), is one of the leading causes of morbidity, and mortality among newborns. We propose to develop a mol ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health -
Development of a novel whole genome amplification method that mimics nature
Amount: $805,716.00DESCRIPTION (provided by applicant): BioHelix is the exclusive licensee for a novel, primase-based Whole Genome Amplification (pWGA) technology invented by Drs. Stanley Tabor and Charles Richardson at ...
SBIRPhase II2008Department of Health and Human Services National Institutes of Health -
Herpes virus typing assay for detecting genital herpes
Amount: $1,893,840.00DESCRIPTION (provided by applicant): The objective of our NIAID Biodefense Phase I SBIR program was to develop, and commercialize field deployable nucleic acid analysis devices for use in biodefense ...
SBIRPhase II2008Department of Health and Human Services National Institutes of Health -
Lateral flow molecular assay for horse strangles
Amount: $80,000.00This proposal seeks to develop a simple, and sensitive molecular diagnostic assay for the detection of Streptococcus equi; the causative agent of strangles. Outbreaks of this disease at racetracks and ...
SBIRPhase I2008Department of Agriculture -
Point of care genotyping assays, and algorithm for warfarin dosing
Amount: $155,774.00DESCRIPTION (provided by applicant): On August 16, 2007, the FDA updated the label for warfarin to include information in the precautions section to remind physicians that people with variations in ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health
